Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Creating Encounters Between Generations - Together Instead of Alone (GemsE) (GemsE)

5 augustus 2026 bijgewerkt door: Silke Wiegand-Grefe, Prof. Dr., Universitätsklinikum Hamburg-Eppendorf

Creating Encounters: Generations in Action - Together Instead of Alone (GemsE)

Elderly people and children and young people (CYP) and from families with mentally ill parents are particularly affected by loneliness. The GemsE project is investigating whether intergenerational mentoring between seniors and children or young people helps to reduce loneliness and improve the mental well-being and quality of life of both groups. The aim of the study is to scientifically record the effect of these sponsorships and to find out how such encounters can be successfully organized.

Studie Overzicht

Toestand

Werving

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

The GemsE project - Creating Encounters: Generations in Action - Together Instead of Alone is an interventional study evaluating intergenerational mentoring between seniors and CYP from families with parents who have mental illness. The aim is to build stable, voluntary relationships that reduce loneliness and improve the mental well-being and health-related quality of life of both groups.

As part of the study, approximately 40 seniors and 40 children or adolescents will be accompanied in sponsorships over a period of six months. The impact of the sponsorships will be measured using standardized, validated questionnaires on loneliness, psychosocial well-being, and health-related quality of life. The results should provide insights into how intergenerational sponsorships can be effectively designed and integrated into psychosocial care services.

Studietype

Ingrijpend

Inschrijving (Geschat)

80

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

  • Naam: Jana Wiehe
  • Telefoonnummer: +4940741024155
  • E-mail: j.wiehe@uke.de

Studie Locaties

  • Duitsland
      • Hamburg, Duitsland, 20246
        • Werving
        • University Medical Center Hamburg-Eppendorf
        • Contact:
        • Contact:
        • Hoofdonderzoeker:
          • Silke Wiegand-Grefe, Prof. Dr.
        • Onderonderzoeker:
          • Theresa Paumen
        • Onderonderzoeker:
          • Jana Wiehe

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind
  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Older adults aged 60 years and older who are residents of Hamburg
  • Children and adolescents aged 12 to 21 years with at least one parent with a mental illness and who are residents of Hamburg
  • Sufficient German language proficiency
  • Ability and willingness to provide informed consent to participate in the study

Exclusion Criteria:

  • Children and adolescents with severe acute psychological symptoms requiring inpatient treatment, including acute suicidality, acute substance use, or acute psychotic symptoms
  • Older adults with acute psychological crises or untreated severe mental illness preventing reliable participation
  • Older adults with cognitive impairment or dementia preventing reliable participation in the intervention

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: NVT
  • Interventioneel model: Opdracht voor een enkele groep
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Establishing intergenerational tandems

The intervention focuses on establishing stable mentoring relationships between senior citizens and children or adolescents from families with parents who have mental health issues.

The main objectives of this intervention are to build reliable relationships, reduce loneliness, and promote mental well-being and quality of life for both groups.

This intervention is coordinated by the project team at GemsE - Creating encounters: Generations in Action - Together Instead of Alone -.
Gedragsmatig: Mechanisms and effectiveness of intergenerational tandems
The project Creating Encounters Between Generations - Together Instead of Alone (German acronym GemsE) aims to provide social support and integration for both groups by establishing tandems between lonely senior citizens and COPMI, and to scientifically evaluate the effectiveness of these tandems. The tandems run for six months, with weekly meetings between senior and CYP. The tandems consist of weekly individual meetings with joint activities such as playing games, learning, cooking, or going for walks. Senior citizens and CYP engage in tandems built on trust, shared experiences, and cooperation, fostering connections that benefit both sides at eye level. Project coordinators accompany the participants and support the process management.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Loneliness
Tijdsspanne: Change from baseline to 6 months.
The primary clinically relevant parameter of the study is the experience of loneliness among children, adolescents, and seniors, measured using the 6-item short version of the De Jong Gierveld Loneliness Scale.The response options are three-point (yes, more or less, no) from 0-6 with higher scores indicating greater loneliness.
Change from baseline to 6 months.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Mental well-being
Tijdsspanne: Change from baseline to 6 months.
The mental well-being of seniors and young adults is assessed using the SDQ 18+, while the SDQ 11-17 is used for self-assessment for adolescents. Scores range from 0 to 40, with higher scores indicating greater psychological difficulties and poorer mental well-being.
Change from baseline to 6 months.
Health-Related Quality of Life in Adults
Tijdsspanne: Change from baseline to 6 months.
Health-related quality of life in participants aged 18 years and older will be assessed using the SF-12. Scores range from 0 to 100, with higher scores indicating better health-related quality of life.
Change from baseline to 6 months.
Health-Related Quality of Life in Children and Adolescents
Tijdsspanne: Change from baseline to 6 months.
Health-related quality of life in participants aged 12 to 17 years will be assessed using the KIDSCREEN-27 Questionnaire. Scores range from 0 to 100, with higher scores indicating better quality of life.
Change from baseline to 6 months.
Health-Related Quality of Life in Adults (EQ-5D-5L)
Tijdsspanne: Change from baseline to 6 months
Health-related quality of life in participants aged 18 years and older will be assessed using the EQ-5D-5L. The instrument assesses five health dimensions across 5 response levels, generating a 5-digit health profile in which lower levels indicate fewer health problems, as well as a visual analogue scale (VAS) score ranging from 0 to 100 and, where applicable, a utility index score typically ranging from below 0 to 1, with higher VAS and utility scores indicating better HRQoL.
Change from baseline to 6 months
Health-Related Quality of Life in Children and Adolescents (EQ-5D-Y-5L)
Tijdsspanne: Change from baseline to 6 months
Health-related quality of life in participants from 12-17 years will be assessed using the EQ-5D-Y-5L. The instrument assesses five health dimensions across 5 response levels, generating a 5-digit health profile in which lower levels indicate fewer health problems, as well as a visual analogue scale (VAS) score ranging from 0 to 100 and, where applicable, a utility index score typically ranging from below 0 to 1, with higher VAS and utility scores indicating better HRQoL.
Change from baseline to 6 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Onderzoekers

  • Hoofdonderzoeker: Silke Wiegand-Grefe, Prof. Dr., Universitätsklinikum Hamburg-Eppendorf

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 september 2026

Primaire voltooiing (Geschat)

1 december 2026

Studie voltooiing (Geschat)

1 december 2026

Studieregistratiedata

Eerst ingediend

24 maart 2026

Eerst ingediend dat voldeed aan de QC-criteria

6 mei 2026

Eerst geplaatst (Werkelijk)

12 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

10 augustus 2026

Laatste update ingediend die voldeed aan QC-criteria

5 augustus 2026

Laatst geverifieerd

1 augustus 2026

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • 2025-101662-BO-ff

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren